Ledger.Open graph →
SEC Form D · filed August 17, 2020

PHOENIX BIOTECHNOLOGY INC

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN ANTONIO, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Robert A. Newman · San Antonio, TXExec · DirectorAndrew J. Butler · San Antonio, TXDirectorCrandell Addington · San Antonio, TXExec · DirectorLou T. Kost · San Antonio, TXExec · DirectorMacdonald T. Haskell · San Antonio, TXDirectorJeffrey S. Thompson · San Antonio, TXDirectorAndrew J. Whitney · San Antonio, TXDirectorTadataka M. Yamada · Seattle, WAExec · DirectorDavid W. Davis · Louisville, KYDirectorStephen S. Sypherd · Philadelphia, PADirectorGreg F. Gruning · Cuyahoga Falls, OHExec · DirectorGary T. Salhany · Cuyahoga Falls, OHExec · DirectorW. M. Bryant · Louisville, KYDirectorFrank Sena · SEATTLE, WADirectorRobb Monkman · SEATTLE, WADirectorBrian K. Sullivan · Canton, GAExec · DirectorChris Allen · Alpharetta, GAExec · DirectorIgniteXL Ventures GP, LLC · Palo Alto, CADirectorMichael Hacke · Pittsburgh, PAExec · DirectorAndrew J. Whitney · San Antonio, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗